This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization US

Early Registration Savings Deadline Expires In

  • 00
  • 00
  • 00
  • 00
Delivered as a Hybrid Event
September 27-30, 2022Boston Convention and Exhibition Center

James Bolling
Associate Director, Process Development at Precision BioSciences


James Bolling leads Cell Therapy Process Development at Precision BioSciences. Since joining Precision BioSciences in 2017, he has focused on the development and refinement of Precision’s best-in-class allogeneic CAR T manufacturing platform and has supported four IND submissions and clinical candidates. Prior to joining Precision BioSciences, James worked at MedImmune (AstraZeneca), where he developed upstream bioreactor processes for early-stage mAb candidates and an autologous CAR T platform process. James received his BS in Biology and BA in Economics from the University of Virginia, and MS in Biotechnology from Northwestern University.

Agenda Sessions

  • Development of a Robust Allogeneic CAR T Manufacturing Process Using the ARCUS® Genome Editing Technology